Page last updated: 2024-08-21

alpha-aminopyridine and Muscular Weakness

alpha-aminopyridine has been researched along with Muscular Weakness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barreiro, E; Casadevall, C; Gea, J; Pascual-Guardia, S; Puig-Vilanova, E; Salazar-Degracia, A	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Muscular Weakness

Article	Year
The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia. Journal of applied physiology (Bethesda, Md. : 1985), 2018, 08-01, Volume: 125, Issue:2 Topics: Aminopyridines; Autophagy; Benzamides; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Cyclopropanes; Female; Humans; Male; Middle Aged; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Phosphodiesterase 4 Inhibitors; Proteolysis; Pulmonary Disease, Chronic Obstructive	2018

Article

Year

The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.

Journal of applied physiology (Bethesda, Md. : 1985), 2018, 08-01, Volume: 125, Issue:2

Topics: Aminopyridines; Autophagy; Benzamides; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Cyclopropanes; Female; Humans; Male; Middle Aged; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Phosphodiesterase 4 Inhibitors; Proteolysis; Pulmonary Disease, Chronic Obstructive

2018